50 related articles for article (PubMed ID: 12439433)
1. [Diabetic cardiopathy: pathogenesis, diagnosis and therapy].
Tschöpe C; Schultheiss HP
Internist (Berl); 2003 Jul; 44(7):806-12, 814-8. PubMed ID: 14631577
[TBL] [Abstract][Full Text] [Related]
2. Heart disease in diabetic patients.
Blendea MC; McFarlane SI; Isenovic ER; Gick G; Sowers JR
Curr Diab Rep; 2003 Jun; 3(3):223-9. PubMed ID: 12762970
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
[TBL] [Abstract][Full Text] [Related]
4. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).
Montalescot G; Van de Werf F; Gulba DC; Avezum A; Brieger D; Kennelly BM; Mazurek T; Spencer F; White K; Gore JM;
Catheter Cardiovasc Interv; 2003 Nov; 60(3):360-7. PubMed ID: 14571488
[TBL] [Abstract][Full Text] [Related]
5. Targeting the use of glycoprotein IIb/IIIa antagonists--the diabetic patient.
Meier-Ewert HK; Nesto RW
Rev Cardiovasc Med; 2002; 3 Suppl 1():S20-7. PubMed ID: 12439433
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
Bolognese L
Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
[TBL] [Abstract][Full Text] [Related]
7. Platelets and antiplatelet therapy in patients with diabetes mellitus.
Arjomand H; Roukoz B; Surabhi SK; Cohen M
J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635
[TBL] [Abstract][Full Text] [Related]
8. [Percutaneous coronary intervention in diabetic patients].
Lablanche JM; Rosey G; Zoubidi M; Sudre A
Bull Acad Natl Med; 2005 Feb; 189(2):249-56. PubMed ID: 16114856
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?
Maree A; Fitzgerald DJ
Semin Vasc Med; 2003 Nov; 3(4):385-90. PubMed ID: 15199445
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
